Merck (MRK) Other Non-Current Assets (2009 - 2026)

Merck (MRK) has reported Other Non-Current Assets for 17 consecutive years, with $19.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 10.98% year-over-year to $19.6 billion in Q2 2026; TTM through Jun 2026 was $19.6 billion, a 10.98% increase from a year earlier, with the FY2025 full-year figure at $18.8 billion, up 17.29% from the prior year.
• Other Non-Current Assets was $19.6 billion for Q2 2026 at Merck, down from $19.8 billion in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $19.8 billion in Q1 2026 and troughed at $323.0 million in Q3 2022.
• A 5-year average of $11.2 billion and a median of $12.5 billion in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 67.76% in 2023 and jumped 3186.93% in 2024, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $9.5 billion in 2022, then increased by 25.9% to $12.0 billion in 2023, then jumped by 33.74% to $16.0 billion in 2024, then rose by 17.29% to $18.8 billion in 2025, then rose by 4.18% to $19.6 billion in 2026.
• The last three Other Non-Current Assets figures came in at $19.6 billion (Q2 2026), $19.8 billion (Q1 2026), and $18.8 billion (Q4 2025), per Business Quant data.